NCT04157738View on ClinicalTrials.gov

A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

December 17, 2020

Study Completion Date

December 17, 2020

Conditions
Diabetes MellitusType 1 Diabetes
Interventions
DRUG

Rapid-Acting Insulin

Prior to discharge, all subjects will receive a regimen that includes a Meal-time insulin and carbohydrate regimen (number of units of insulin, number of carbohydrates, and/or ICR)

DRUG

Long acting insulin

Prior to discharge, all subjects will receive a regimen that includes a daily dose of long-acting insulin (Glargine)

Trial Locations (1)

30322

Children's Healthcare of Atlanta, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT04157738 - A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter